Hims & Hers Health, Inc. (BMV:HIMS)
Mexico flag Mexico · Delayed Price · Currency is MXN
252.08
-11.72 (-4.44%)
At close: Feb 27, 2026

Hims & Hers Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,3481,477872526.92271.88
Revenue Growth (YoY)
59.00%69.33%65.49%93.81%82.77%
Cost of Revenue
614.26303.38157.05118.1967.38
Gross Profit
1,7331,173714.95408.72204.49
Selling, General & Admin
1,4631,028693.16445.86289.05
Research & Development
149.378.8248.2329.2422.38
Operating Expenses
1,6121,107741.39475.1311.43
Operating Income
121.1665.88-26.44-66.38-106.94
Interest Expense
-3.9----
Interest & Investment Income
23.5310.359.032.610.39
Other Non Operating Income (Expenses)
-5.75-0.54-1.150.383.86
EBT Excluding Unusual Items
135.0375.69-18.56-63.39-102.69
Gain (Loss) on Sale of Investments
4.44----
Asset Writedown
----1.13-
Other Unusual Items
-15.54-3.98-3.02-1.19-8.11
Pretax Income
123.9271.71-21.57-65.71-110.8
Income Tax Expense
-4.44-54.331.98-0.03-3.14
Net Income
128.37126.04-23.55-65.68-107.66
Net Income to Common
128.37126.04-23.55-65.68-107.66
Net Income Growth
1.85%----
Shares Outstanding (Basic)
225216209205187
Shares Outstanding (Diluted)
258237209205187
Shares Change (YoY)
9.05%13.12%2.36%9.50%428.32%
EPS (Basic)
0.570.58-0.11-0.32-0.58
EPS (Diluted)
0.510.53-0.11-0.32-0.58
EPS Growth
-3.75%----
Free Cash Flow
73.96209.4356.26-29.25-35.24
Free Cash Flow Per Share
0.290.880.27-0.14-0.19
Gross Margin
73.83%79.45%81.99%77.57%75.22%
Operating Margin
5.16%4.46%-3.03%-12.60%-39.33%
Profit Margin
5.47%8.54%-2.70%-12.46%-39.60%
Free Cash Flow Margin
3.15%14.18%6.45%-5.55%-12.96%
EBITDA
175.6682.97-16.92-58.9-102.86
EBITDA Margin
7.48%5.62%-1.94%-11.18%-37.83%
D&A For EBITDA
54.517.099.527.474.08
EBIT
121.1665.88-26.44-66.38-106.94
EBIT Margin
5.16%4.46%-3.03%-12.60%-39.33%
Advertising Expenses
814.9604.6390.3235.6103.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.